Tag: Cannara Biotech Inc.
February 20, 2020
Cannara Insiders Form Buying Group to Fully Acquire FSD/FV Pharma’s Position in Cannara
Insiders' increase stake in Cannara coincides as cultivation poised to commence
February 20, 2020
FSD Pharma Generates $7.7 Million in Proceeds and 670 Percent Return on Investment through Sale of Interest in Cannara Biotech
FSD Pharma Inc. (NASDAQ:HUGE) (CSE:HUGE) (FRA:0K9A) today announced the sale of its 12% equity interest in Cannara Biotech Inc. February 3, 2020
Cannara Biotech’s Farnham Facility Receives Cultivation Licence
Cannara Biotech Inc. announced the receipt of its cultivation licence from Health Canada for Phase 1 of its purpose-built Farnham... January 20, 2020
Cannara Biotech Reports Q1 2020 Financial Results
Cannara Biotech Inc. (CSE:LOVE, OTCQB:LOVFF, FRA:8CB) announced financial results for the three-month period ended November 30, 2019. November 27, 2019
Cannara Biotech Reports Q4 and Year-End 2019 Financial Results
Cannara Biotech Inc. (CSE:LOVE, FRA:8CB, OTCQB:LOVFF) announced financial results for the three month period and year ended August 31, 2019. October 10, 2019
Cannara Biotech Secures $6 Million Mortgage Financing Facility with Canadian Imperial Bank of Commerce
Cannara Biotech announced it has secured a mortgage against its Farnham Facility in the value of $6 million with the Canadian Imperial...
September 12, 2019